Amylyx Pharmaceuticals, Inc. Inventory, Noncurrent
Amylyx Pharmaceuticals, Inc. (AMLX) had Inventory, Noncurrent of $44.96 million as of 2023-12-31, per its 10-K filed 2025-03-04.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InventoryNoncurrent · last filed 2025-03-04
- 2023-12-31: Inventory, Noncurrent $44.96M.
- 2023-09-30: Inventory, Noncurrent $24.33M.
- 2023-06-30: Inventory, Noncurrent $17.73M.
- 2023-03-31: Inventory, Noncurrent $10.07M.
| Period end | Inventory, Noncurrent |
|---|---|
| 2023-12-31 | $44.96M 10-K · filed 2025-03-04 |
| 2023-09-30 | $24.33M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $17.73M 10-Q · filed 2023-08-10 |
| 2023-03-31 | $10.07M 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Enliven Therapeutics, Inc. (ELVN) | United States | $3.307B | -35.07 |
| Arcutis Biotherapeutics, Inc. (ARQT) | United States | $3.303B | 115.47 |
| Arcus Biosciences, Inc. (RCUS) | United States | $3.188B | -8.52 |
| IDEAYA Biosciences, Inc. (IDYA) | United States | $3.540B | -20.52 |
| Organon & Co. (OGN) | United States | $3.603B | 17.03 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| Xenon Pharmaceuticals Inc. (XENE) | $3.684B | -14.27 | |
| ACADIA PHARMACEUTICALS INC (ACAD) | United States | $3.823B | 11.45 |
| AbCellera Biologics Inc. (ABCL) | $3.879B | -14.59 | |
| PRECIGEN, INC. (PGEN) | United States | $2.757B | -12.94 |